1660318540197 Number2

Pharma in review: trending stories 7/12/19

July 12, 2019

GSK opens continuous manufacturing plants

The drugmaker has opened two “state-of-the-art” facilities in Singapore with continuous manufacturing capabilities.

Trump suggests executive order on drug prices
The President said that the White House was writing an executive order to require pharma companies to offer the U.S. government lower prices — but did not elaborate on details.
Biosimilars are coming to LATAM

Latin American has a flourishing biosimilar industry, with its own research, development, production and commercialization capacity.

Fosun buys GSK plant, hepatitis B drug rights

The drugmaker has announced plans for its subsidiary to spend up to $36 million to buy GSK's Suzhou pharma factory in east China.

Novartis offers generic epinephrine shots in U.S.

Sandoz has made its Symjepi epinephrine shots immediately available in U.S. pharmacies amid a continuing EpiPen shortage.